Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.